Exploring public opinion about liability and responsibility in surgical robotics with the iRobotSurgeon survey
This article explores the legal, ethical, and public perception challenges surrounding liability and responsibility in surgical robotics as systems become increasingly autonomous. It introduces a six-level classification system for surgical robot autonomy and describes the iRobotSurgeon survey, which uses five hypothetical scenarios to gauge public opinion on who bears responsibility when a patient is harmed. The authors discuss existing tort law, product liability, the 'component part' doctrine, and the concept of the 'moral crumple zone' where human operators may bear a disproportionate burden of blame.
Summary and content fields are drawn from the document text and are pending editorial review.
Who issued it
Who it governs
Researchers, regulators, policymakers, and medical professionals interested in the legal and ethical implications of surgical robotics and AI autonomy should read this.
What the document contains
The document addresses the legal, ethical, and liability challenges associated with increasing levels of autonomy in surgical robotic systems. It discusses product liability, tort law negligence standards, component part doctrines, and introduces the iRobotSurgeon survey designed to evaluate public perceptions of responsibility across various surgical failure scenarios.
The text does not provide binding regulatory rules, formal legal enforcement mechanisms, specific policy directives, or definitive legal rulings on surgical robot liability.
- Increasing autonomy in surgical robots creates complex legal challenges in determining liability when patient harm occurs.
- The iRobotSurgeon survey uses five distinct hypothetical scenarios to explore public attitudes toward responsibility among surgeons, manufacturers, and hospitals.
- Current tort law struggles with applying negligence standards like 'reasonably prudent' behavior to machine learning systems that display unforeseen behaviors.
- The 'moral crumple zone' concept highlights the risk that human operators may bear a disproportionate share of responsibility for complex automated system failures.
- Existing legal precedents such as product liability and the component part doctrine offer limited clarity for third-party algorithmic software errors.
· Introduction · Classification of surgical robotic systems · Current state of surgical robotic systems and the legal landscape · Parallels with autonomous vehicles and the moral crumple zone · The iRobotSurgeon Survey · Table 1: Five scenarios describing robotic surgical systems of increasing autonomy
How it scores
Each score is backed by a quote verified against the document text. Editorial review has not yet confirmed them.
Accountability
3/5Clear responsibility for AI outcomes
The iRobotSurgeon survey (www.iRobotSurgeon.com) explores public opinions about questions of responsibility and liability in the area of surgical robotics.
ABSTRACT
screening score · 2026-10-23
Fairness
0/5Non-discrimination and equitable treatment
None
screening score · 2026-10-23
Human Dignity
0/5Respect for the inherent worth of persons
None
screening score · 2026-10-23
Human Oversight
2/5Humans remain in control of consequential decisions
There is, however, concern that human actors may shoulder a disproportionate burden of responsibility in the event of damages involving complex automated systems.
Parallels with autonomous vehicles and the moral crumple zone
screening score · 2026-10-23
Privacy
0/5Protection of personal data and private life
None
screening score · 2026-10-23
Transparency
1/5Openness about how AI systems work and are used
A six-level classification system for autonomy exists for surgical robotic systems, based on the level of involvement of the operator
Classification of surgical robotic systems
screening score · 2026-10-23
Enforcement
0/5Consequences and compliance mechanisms with real force
None
screening score · 2026-10-23
Impact Assessment
0/5Required assessment of an AI system's risks/impacts before or during use
None
screening score · 2026-10-23